<i><scp>MYC</scp>/<scp>BCL</scp>6</i> double‐hit lymphoma (<scp>DHL</scp>): a tumour associated with an aggressive clinical course and poor prognosisShaoying Li, L. Jeffrey Medeiros, Carlos E. Bueso-Ramos et al.|Histopathology|2015Cited by 106
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphomaXuan J. Wang, Shaoying Li, L. Jeffrey Medeiros et al.|Modern Pathology|2016Cited by 92
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (<scp>MCL</scp>) ‐ outcomes and mutation profile from venetoclax resistant <scp>MCL</scp> patientsShuangtao Zhao, Preetesh Jain, Rashmi Kanagal‐Shamanna et al.|American Journal of Hematology|2020Cited by 84
Prognostic Factors of Hepatosplenic T-cell LymphomaMariko Yabe, Roberto N. Miranda, L. Jeffrey Medeiros et al.|The American Journal of Surgical Pathology|2016Cited by 82